Skip to content

Studying the Effects of Carcinosin in Treating Respiratory Illnesses in Patients

Study The Role Of Carcinosinum In Respiratory Illness - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078992
Enrollment
30
Registered
2025-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: Carcinosin: Carcinosin Medicine Dose As Per Requirement Of Case Through Sublingual mode of Administration According To Case within time duration of 9 Months Control Intervention1: N

Sponsors

C D Pachchigar College Of Homoeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of all age groups, both sexes will be considered. Patient having chief complaint of respiratory illness will be considered.

Exclusion criteria

Exclusion criteria: Disease with severe systemic disease will excluded from the study. Cases with the irreversible pathology, congenital anomaly will excluded from the study. Cases with emergency condition will excluded from the study, any surgical cases will excluded from the study.

Design outcomes

Primary

MeasureTime frame
To study the utility of carcinosin in different respiratory illnessesTimepoint: 9 Months

Secondary

MeasureTime frame
To understand the characteristic symptoms, sphere of action and clinical application of carcinosin in different respiratory illnesses.Timepoint: As per condition of patient

Countries

India

Contacts

Public ContactDr Manish Doctor

C D Pachchigar College Of Homoeopathic Medicine And Hospital

doctormanishvadan@yahoo.co.in9998667227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026